James Woods, Ph.D.
Assistant VP of Research
Research and Sponsored Programs
- Assistant VP of ResearchResearch and Sponsored Programs
RESEARCH INTERESTS
Dr. Woods’ research interests include rheumatoid arthritis, inflammation and angiogenesis. Select peer-reviewed publications include:
Woods JM, Ricken JM, and MJ Druse: Effects of chronic alcohol consumption and aging on dopaime D1 receptors in Fischer 344 rats. Alcohol: Clin. Exp. Res. 19:1331-1337, 1995
Woods JM, and MJ Druse: Effects of chronic ethanol consumption and aging on dopamine, serotonin, and metabolites. J. Neurochem. 66:2168-2178, 1996.
Woods JM, Haines GK, Shah MR, Rayan G, and AE Koch: Low-level production of interleukin-13 in synovial fluid and tissue from patients with arthritis. Clin. Immunol. Immunopath. 85:210-220, 1997.
Woods JM, Tokuhira M, Berry JC, Katschke KJ, Kurata H, Damergis JA Jr., Arai K-I, and AE Koch: Interleukin-4 adenoviral gene therapy reduces production of inflammatory cytokines and prostaglandin E2 by rheumatoid arthritis synovium in vitro. J. Investig. Med. 47:285-292, 1999.
Woods JM, Katschke KJ, Tokuhira M, Kurata H, Arai K-I, Campbell PL, and AE Koch: Reduction of inflammatory cytokines, chemokines, and prostaglandin E2 by IL-13 gene therapy in rheumatoid arthritis synovium. J. Immunol. 165:2755-2763, 2000.
Woods JM, Katschke KJ, Volin MV, Ruth JH, Woodruff DC, Amin MA, Connors MA, Kurata H, Arai KI, Kumar P, and AE Koch: Interleukin-4 adenoviral gene therapy reduces inflammation, proinflammatory cytokines, vascularization, and bony destruction in rat adjuvant-induced arthritis. J. Immunol. 166:1214-1222, 2001.
Woods JM, Amin MA, Katschke KJ, Volin MV, Ruth JH, Connors MA, Woodruff DC, Kurata H, Arai KI, Haines GK, Kumar P, and AE Koch: Interleukin-13 gene therapy reduces inflammation, vascularization, and bony destruction in rat adjuvant-induced arthritis. Hum. Gene Ther. 13:381-393, 2002.
Hu X, Li WP, Herrero C, Li WP, Antoniv TT, Falck-Pedersen E, Koch AE, Woods JM, Haines GK, and LB Ivashkiv: Sensitization of IFN Jak-STAT signaling during macrophage activation. Nat. Immunol. 3:859-866, 2002.
Woods JM, Mogollon A, Amin MA, Martinez R,J and AE Koch: The role of COX-2 in angiogenesis and rheumatoid arthritis. Exp. Mol. Path. 74:282-290, 2003.
Shahrara S, Proudfoot AE, Woods JM, Ruth JH, Amin MA, Park CC, Haas CS, Pope RM, Haines GK, Zha YY and AE Koch: Amelioration of rat adjuvant-induced arthritis by Met-RANTES. Arthritis Rheum. 52:1907-1919, 2005.
Woods JM, Klosowska K, Spoden DJ, Stumbo NG, Paige DJ, Scatizzi JC, Volin MV, Rao M and Perlman H: A cell-cycle independent role for p21 in regulating synovial fibroblast migration in rheumatoid arthritis. Arthritis Res. & Ther. 8:R113, 2006.
Volin MV, Huynh N, Klosowska K, Chong KK, and Woods JM: Fractalkine is a novel chemoattractant for rheumatoid arthritis fibroblast-like synoviocytes signaling through MAP kinases and Akt. Arthritis Rheum. 56:2512-2522, 2007.
Volin MV, Shahrara S, Haines GK, Woods JM, and Koch AE: Expression of Mucin 3 and Mucin 5AC in Arthritic Synovial Tissue. Arthritis Rheum. 58:46-52, 2008.
Klosowska K, Volin MV, Huynh N, Chong KK, Halloran MM, and JM Woods: Fractalkine functions as a chemoattractant for osteoarthritis synovial fibroblasts and stimulates phosphorylation of MAP kinases and Akt. Clin. Exp. Immunol., 156:312-319, 2009.
Volin MV, Huynh N, Klosowska K, Reyes RD, and JM Woods: Fractalkine-Induced Endothelial Cell Migration Requires MAP Kinase Signaling. Pathobiology. 77:7-16, 2010.
Woods JM, Ricken JM, and MJ Druse: Effects of chronic alcohol consumption and aging on dopaime D1 receptors in Fischer 344 rats. Alcohol: Clin. Exp. Res. 19:1331-1337, 1995
Woods JM, and MJ Druse: Effects of chronic ethanol consumption and aging on dopamine, serotonin, and metabolites. J. Neurochem. 66:2168-2178, 1996.
Woods JM, Haines GK, Shah MR, Rayan G, and AE Koch: Low-level production of interleukin-13 in synovial fluid and tissue from patients with arthritis. Clin. Immunol. Immunopath. 85:210-220, 1997.
Woods JM, Tokuhira M, Berry JC, Katschke KJ, Kurata H, Damergis JA Jr., Arai K-I, and AE Koch: Interleukin-4 adenoviral gene therapy reduces production of inflammatory cytokines and prostaglandin E2 by rheumatoid arthritis synovium in vitro. J. Investig. Med. 47:285-292, 1999.
Woods JM, Katschke KJ, Tokuhira M, Kurata H, Arai K-I, Campbell PL, and AE Koch: Reduction of inflammatory cytokines, chemokines, and prostaglandin E2 by IL-13 gene therapy in rheumatoid arthritis synovium. J. Immunol. 165:2755-2763, 2000.
Woods JM, Katschke KJ, Volin MV, Ruth JH, Woodruff DC, Amin MA, Connors MA, Kurata H, Arai KI, Kumar P, and AE Koch: Interleukin-4 adenoviral gene therapy reduces inflammation, proinflammatory cytokines, vascularization, and bony destruction in rat adjuvant-induced arthritis. J. Immunol. 166:1214-1222, 2001.
Woods JM, Amin MA, Katschke KJ, Volin MV, Ruth JH, Connors MA, Woodruff DC, Kurata H, Arai KI, Haines GK, Kumar P, and AE Koch: Interleukin-13 gene therapy reduces inflammation, vascularization, and bony destruction in rat adjuvant-induced arthritis. Hum. Gene Ther. 13:381-393, 2002.
Hu X, Li WP, Herrero C, Li WP, Antoniv TT, Falck-Pedersen E, Koch AE, Woods JM, Haines GK, and LB Ivashkiv: Sensitization of IFN Jak-STAT signaling during macrophage activation. Nat. Immunol. 3:859-866, 2002.
Woods JM, Mogollon A, Amin MA, Martinez R,J and AE Koch: The role of COX-2 in angiogenesis and rheumatoid arthritis. Exp. Mol. Path. 74:282-290, 2003.
Shahrara S, Proudfoot AE, Woods JM, Ruth JH, Amin MA, Park CC, Haas CS, Pope RM, Haines GK, Zha YY and AE Koch: Amelioration of rat adjuvant-induced arthritis by Met-RANTES. Arthritis Rheum. 52:1907-1919, 2005.
Woods JM, Klosowska K, Spoden DJ, Stumbo NG, Paige DJ, Scatizzi JC, Volin MV, Rao M and Perlman H: A cell-cycle independent role for p21 in regulating synovial fibroblast migration in rheumatoid arthritis. Arthritis Res. & Ther. 8:R113, 2006.
Volin MV, Huynh N, Klosowska K, Chong KK, and Woods JM: Fractalkine is a novel chemoattractant for rheumatoid arthritis fibroblast-like synoviocytes signaling through MAP kinases and Akt. Arthritis Rheum. 56:2512-2522, 2007.
Volin MV, Shahrara S, Haines GK, Woods JM, and Koch AE: Expression of Mucin 3 and Mucin 5AC in Arthritic Synovial Tissue. Arthritis Rheum. 58:46-52, 2008.
Klosowska K, Volin MV, Huynh N, Chong KK, Halloran MM, and JM Woods: Fractalkine functions as a chemoattractant for osteoarthritis synovial fibroblasts and stimulates phosphorylation of MAP kinases and Akt. Clin. Exp. Immunol., 156:312-319, 2009.
Volin MV, Huynh N, Klosowska K, Reyes RD, and JM Woods: Fractalkine-Induced Endothelial Cell Migration Requires MAP Kinase Signaling. Pathobiology. 77:7-16, 2010.